Target intelligence / Profile preview

Amylolytic Enzymes (Small Intestine) (N/A)

Target
N/A
Molecular classification
Enzyme, Hydrolase, Glycosidase
01

Overview

Amylolytic enzymes in the small intestine, including pancreatic alpha-amylase, maltase-glucoamylase, and sucrase-isomaltase, are crucial for the digestion of glycogen and starch. These enzymes break down complex carbohydrates into absorbable monosaccharides, primarily glucose, which is essential for energy production. Inhibition of these enzymes, such as with alpha-glucosidase inhibitors, is a therapeutic strategy for managing postprandial hyperglycemia in type 2 diabetes mellitus.

Other names
Small Intestinal AmylasesPancreatic alpha-amylaseMaltase-glucoamylaseSucrase-isomaltaseBrush Border Enzymes (Carbohydrate Digestion)
02

Mechanism of action

Alpha-glucosidase inhibitors (acarbose, miglitol, voglibose) competitively inhibit alpha-glucosidases in the small intestine, delaying glucose absorption and reducing postprandial hyperglycemia.

03

Biological functions

Carbohydrate digestionGlycogen hydrolysisStarch hydrolysisGlucose production
04

Disease associations

Malabsorption syndromesType 2 Diabetes Mellitus (indirectly, via glucose regulation)Enzyme deficiencies (e.g., sucrase-isomaltase deficiency)
05

Safety considerations

Gastrointestinal side effects (e.g., flatulence, diarrhea) associated with alpha-glucosidase inhibitors due to undigested carbohydrates reaching the colon.Hypoglycemia when used in combination with other antidiabetic drugs.Potential for malabsorption if enzyme activity is severely impaired.
06

Interacting drugs

Acarbose

2 more in the full profile.

Beyond the preview

Go deeper on Amylolytic Enzymes (Small Intestine) (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amylolytic Enzymes (Small Intestine) (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call